USP21-EGFR-Lyn axis drives NSCLC progression and therapeutic potential of USP21 inhibition by Ji Hye Shin, Ji Young Kim, Mi-Jeong Kim, Yeeun Kang, Bongkum Choi, Dohee Kwon, Yoolim Sung, Seo Hyun Kim, Ha-Jeong Lee, Chaeeun Lee, Kyeong Kyu Kim, Jae-Hyuck Shim, Duk-Hwan Kim, Eunyoung Chun, Ki-Young Lee

Get full text